Cargando…
Selective targeting of PPARγ by the natural product chelerythrine with a unique binding mode and improved antidiabetic potency
Type 2 diabetes mellitus (T2DM) is a pervasive metabolic syndrome that is characterized by insulin resistance, hyperglycemia and dyslipidemia. As full agonists of PPARγ, thiazolidinedione (TZD) drugs elicit antidiabetic effects by targeting PPARγ but is accompanied by weight gain, fluid retention an...
Autores principales: | Zheng, Weili, Qiu, Lin, Wang, Rui, Feng, Xuhui, Han, Yaping, Zhu, Yanlin, Chen, Dezhou, Liu, Yijie, Jin, Lihua, Li, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505335/ https://www.ncbi.nlm.nih.gov/pubmed/26183621 http://dx.doi.org/10.1038/srep12222 |
Ejemplares similares
-
Structural Basis for PPARs Activation by The Dual PPARα/γ Agonist Sanguinarine: A Unique Mode of Ligand Recognition
por: Tian, Siyu, et al.
Publicado: (2021) -
Targeting PPAR-γ to design and synthesize antidiabetic thiazolidines
por: Sawant, Ramesh L., et al.
Publicado: (2018) -
Identification of a novel selective PPARγ ligand with a unique binding mode and improved therapeutic profile in vitro
por: Yi, Wei, et al.
Publicado: (2017) -
Using Liposomes to Alleviate the Toxicity of Chelerythrine, a Natural PKC Inhibitor, in Treating Non-Small Cell Lung Cancer
por: Wang, Jiahui, et al.
Publicado: (2021) -
Structures of PPARγ complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs
por: Lee, Min A, et al.
Publicado: (2017)